CI
Cigna CorporationNYSEHealthcare$270.02+1.01%OpenMarket Cap: $72.13B
As of 2026-04-06
Valuation
P/E (TTM)
12.11
PEG
0.16
P/B
1.72
P/S
0.26
EV/EBITDA
8.01
DCF Value
$2,367.27
FCF Yield
11.6%
Div Yield
2.3%
Margins & Returns
Gross Margin
9.5%
Operating Margin
3.3%
Net Margin
2.2%
ROE
14.5%
ROA
7.1%
ROIC
7.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $72.47B | 7.7% | $2.15B | $1.23B | $4.64 | $1.51 |
| FY 2025 | $274.95B | 9.5% | $9.13B | $5.96B | $22.17 | $6.04 |
| Q3 2025 | $69.75B | 8.5% | $2.58B | $1.87B | $6.97 | $1.51 |
| Q2 2025 | $67.23B | 11.7% | $2.43B | $1.53B | $5.71 | $1.51 |
| Q1 2025 | $65.50B | 10.1% | $1.97B | $1.32B | $4.85 | $1.51 |
| Q4 2024 | $65.65B | 9.8% | $2.17B | $1.42B | $5.13 | $1.40 |
| FY 2024 | $247.12B | 10.5% | $9.42B | $3.43B | $12.12 | $5.60 |
| Q3 2024 | $63.69B | 10.4% | $2.58B | $739.0M | $2.63 | $1.40 |
| Q2 2024 | $60.52B | 10.8% | $2.41B | $1.55B | $5.45 | $1.40 |
| Q1 2024 | $57.26B | 11.2% | $2.26B | $-277.0M | $-0.97 | $1.40 |
| Q4 2023 | $51.11B | 12.9% | $2.06B | $1.03B | $3.49 | $1.23 |
| FY 2023 | $195.26B | 12.9% | $8.54B | $5.16B | $17.39 | $4.92 |